Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
Gross margin remained in line with our expectations with ongoing pressure from tariffs, cost inflation and freight, which we continue to actively manage.
Trade disputes, tariffs and low consumer confidence over the past few quarters have cumulatively impacted the market environment.
we offset all the last quarter of the tariff year-over-year impact for us, a pickup in stranded costs and investments.
the year-over-year increase reflects product cost reductions and fixed overhead leverage, partly offset by the impact of tariffs.
the demand we saw last year was very focused on the AI trade data centers, some M&A-driven trades, but a real pause pending some resolution or clarity around tariffs.
By comparison, when our business faced abrupt tariff-related uncertainty in April of 2025, the pause in leasing activity was relatively immediate before flowing out in the following weeks and months.
the economy continues to hold up well despite ongoing concerns and uncertainty regarding tariffs and other policies.
Cost of goods sold deleveraged by 10 basis points, driven by the impact of tariffs and other operational drivers in the MedTech business.
Tariff-related costs moved through the P&L faster than our pricing, leaving us approximately 40 basis points short of our own target.
we'll have relief from aluminum tariffs this year